Back to search
Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 2, open-Label study to evaluate the efficacy and safety of ABSK043 Combined with Osimertinib in participants with EGFR-Mutated locally advanced…
A prospective, controlled Phase II clinical study on the efficacy and safety of the combination of limertinib and bevacizumab versus limertinib monotherapy as f…